Cart
sales@molnova.com
N-Caffeoyl O-methyltyramine
CAS No. 189307-47-9
N-Caffeoyl O-methyltyramine( —— )
Catalog No. M26313 CAS No. 189307-47-9
N-Caffeoyl O-methyltyramine is isolated from Cuscuta reflexa with strong inhibitory activity against α-glucosidase with IC50 of 103.58 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 85 | In Stock |
|
| 5MG | 101 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 330 | In Stock |
|
| 50MG | 477 | In Stock |
|
| 100MG | 693 | In Stock |
|
| 200MG | 918 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Caffeoyl O-methyltyramine
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Caffeoyl O-methyltyramine is isolated from Cuscuta reflexa with strong inhibitory activity against α-glucosidase with IC50 of 103.58 μM.
-
DescriptionN-Caffeoyl O-methyltyramine is isolated from Cuscuta reflexa with strong inhibitory activity against α-glucosidase with IC50 of 103.58 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetGlucokinase
-
RecptorWnt/β-catenin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number189307-47-9
-
Formula Weight313.353
-
Molecular FormulaC18H19NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (797.83 mM)
-
SMILESCOc1ccc(CCNC(=O)\C=C\c2ccc(O)c(O)c2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ting Wang, et al. N-(3-methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide promotes bone formation via the canonical Wnt/β-catenin signaling . pathwayPhytother Res. 2019 Apr;33(4):1074-1083.
molnova catalog
related products
-
Kevetrin hydrochlori...
Kevetrin hydrochloride is a small molecule and activator of the tumor suppressor protein p53, with potential antineoplastic activity.
-
WAY-297848
WAY-297848 is a novel glucokinase activator for the prevention or treatment of hyperglycemia, diabetes mellitus, obesity, dyslipidemia, and metabolic syndrome.
-
AMG-1694
AMG-1694, a potent disruptor of the glucokinase–glucokinase regulatory protein (GK-GKRP) complex, operates by promoting the dissociation of this complex, thereby indirectly enhancing GK enzymatic activity with an IC50 of 7 nM.
